First day Affordable Care Act (ACA) enrollment surpassed numbers from last year; CVS will offer next-day and same-day prescription delivery in 2018; and voter confusion surrounds Ohio's drug-pricing ballot measure.
In the first few days of open enrollment for the Affordable Care Act (ACA), numbers of people enrolling in coverage have surpassed the previous year. On the first day, more than 200,000 Americans chose a plan, which is more than double the number who signed up on day 1 in 2016, reported The Washington Post. Despite the White House reducing funding for promoting the ACA, traffic to HealthCare.gov was up 33% over last year. State exchanges are reporting similar increases. For example, Colorado reported more than 4000 people logged into the exchange, far surpassing the expected 2700.
With Amazon’s potential entry hanging over the pharmacy industry, CVS has announced a new strategy to offer next-day delivery of prescription drugs in 2018. In some big cities, CVS will offer same-day service, according to The New York Times. The announcement also follows falling retail sales, including prescription sales. At this time, the delivery partner for CVS has not yet been announced.
Ads around Ohio’s Drug Price Relief Act has muddied the waters and caused confusion for voters, who will need to weigh in on the single ballot-box question next week. According to Kaiser Health News, the act is supposed to combat rising drug costs, and the issue has gotten a lot of attention. Opponents and supporters have spent $58 million and $14 million, respectively. A similar measure was rejected in California last year.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen